- Home
- CUE vs DIT Comparison
CUE vs DIT Comparison
Compare CUE & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- DIT
- Stock Information
- Founded
- CUE 2014
- DIT 1981
- Country
- CUE United States
- DIT United States
- Employees
- CUE N/A
- DIT N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- DIT Food Distributors
- Sector
- CUE Health Care
- DIT Consumer Discretionary
- Exchange
- CUE Nasdaq
- DIT Nasdaq
- Market Cap
- CUE 77.3M
- DIT 78.7M
- IPO Year
- CUE 2018
- DIT 1995
- Fundamental
- Price
- CUE $1.07
- DIT $135.00
- Analyst Decision
- CUE Strong Buy
- DIT
- Analyst Count
- CUE 5
- DIT 0
- Target Price
- CUE $5.00
- DIT N/A
- AVG Volume (30 Days)
- CUE 378.2K
- DIT 212.0
- Earning Date
- CUE 11-14-2024
- DIT 01-16-2025
- Dividend Yield
- CUE N/A
- DIT 0.53%
- EPS Growth
- CUE N/A
- DIT N/A
- EPS
- CUE N/A
- DIT 7.15
- Revenue
- CUE $9,532,000.00
- DIT $2,141,481,108.00
- Revenue This Year
- CUE $105.39
- DIT N/A
- Revenue Next Year
- CUE N/A
- DIT N/A
- P/E Ratio
- CUE N/A
- DIT $19.03
- Revenue Growth
- CUE 149.53
- DIT 8.41
- 52 Week Low
- CUE $0.45
- DIT $118.25
- 52 Week High
- CUE $3.20
- DIT $209.50
- Technical
- Relative Strength Index (RSI)
- CUE 45.52
- DIT 46.90
- Support Level
- CUE $0.92
- DIT $134.43
- Resistance Level
- CUE $1.09
- DIT $149.00
- Average True Range (ATR)
- CUE 0.11
- DIT 5.67
- MACD
- CUE 0.00
- DIT -0.56
- Stochastic Oscillator
- CUE 45.71
- DIT 13.41
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.